期刊文献+

社区人群脂蛋白(a)浓度的5年变化趋势及其影响因素研究

Study on the 5-year trend and influencing factors of lipoprotein (a) concentration in community-based population
原文传递
导出
摘要 目的探讨中国社区人群血循环脂蛋白(a)[Lp(a)]浓度随时间的变化趋势及其影响因素。方法本研究为前瞻性队列研究。入选中国多省市心血管病队列研究中参加2002年和2007年2次心血管病危险因素调查,并检测血清Lp(a)浓度的北京社区队列人群。根据基线(2002年)和复查(2007年)时的Lp(a)浓度,将研究对象分为<30.0 mg/dl(1 mg/dl=0.01 g/L)组,30.0~49.9 mg/dl组和≥50.0 mg/dl组。使用多因素logistic回归分析筛选与5年内Lp(a)绝对变化≥20.0 mg/dl或Lp(a)相对变化≥20%相关的因素。结果入选的1955名研究对象基线年龄为(56.5±8.0)岁,男性821人(42.0%)。基线Lp(a)浓度<30.0 mg/dl组,30.0~49.9 mg/dl组和≥50.0 mg/dl组分别有1657人(84.8%),184人(9.4%)和114人(5.8%)。5年间,基线Lp(a)浓度30.0~49.9 mg/dl组中有68人(37.0%)进展为Lp(a)≥50.0 mg/dl,102人(55.4%)仍维持在该水平。Lp(a)<30.0 mg/dl组(92.0%,1524/1657)或Lp(a)≥50.0 mg/dl组(94.7%,108/114)的更倾向于维持在各自水平。多因素logistic回归分析结果显示,除基线Lp(a)高浓度外,心血管病家族史、空腹血糖升高及口服降脂药物是Lp(a)变化的影响因素(P均<0.05)。结论边缘高Lp(a)浓度(30.0~49.9 mg/dl)的成年人可以考虑重复检测,尤其是有心血管病家族史、空腹血糖升高及口服他汀类药物的人群。 Objective To explore the trend and influencing factors of serum lipoprotein(a)(Lp(a))concentration over time in Chinese community populations.Methods This study is a prospective cohort study.The participants were enrolled from Chinese Multi-provincial Cohort Study-Beijing projects,completed the cardiovascular disease risk factor surveys in 2002 and 2007,and the serum Lp(a)concentration were measured.Based on the Lp(a)concentration at baseline(2002)and follow-up(2007),the participants were classified into subgroups of<30.0 mg/dl(1 mg/dl=0.01 g/L)group,30.0 to 49.9 mg/dl group,and≥50.0 mg/dl group,respectively.Multivariable logistic regression analysis was used to identify influencing factors associated with Lp(a)absolute change(≥20 mg/dl)and relative change(≥20%)within 5 years.Results Among 1955 participants with age of(56.5±8.0)years old and 821 male(42.0%)at baseline,there were 1657(84.8%),184(9.4%)and 114(5.8%)participants in Lp(a)<30.0 mg/dl group,30.0 to 49.9 mg/dl group and≥50.0 mg/dl group,respectively.Among the baseline Lp(a)concentration of 30.0-49.9 mg/dl group,68(37.0%)participants progressed to Lp(a)≥50.0 mg/dl after 5 years follow-up,and 102(55.4%)remained at this level.Participants with baseline Lp(a)<30.0 mg/dl(92%,1524/1657)or Lp(a)≥50.0 mg/dl(94.7%,108/114)tended to be maintained at their respective levels.The results of the multivariate logistic regression analysis showed that,in addition to the high level of baseline Lp(a)concentration,family history of cardiovascular disease,elevated fasting blood glucose and usage of oral lipid-lowering drugs were the influencing factors of Lp(a)changes over time(P<0.05).Conclusions Adults with borderline-high Lp(a)concentrations(30.0 to 49.9 mg/dl)could be considered for repeated testing,especially for those with a family history of cardiovascular disease,elevated fasting blood glucose and usage of statins.
作者 张芸淇 段又菱 孙佳艺 刘静 齐玥 Zhang Yunqi;Duan Youling;Sun Jiayi;Liu Jing;Qi Yue(Center for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing 100029,China)
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2023年第12期1234-1239,共6页 Chinese Journal of Cardiology
基金 北京市自然科学基金项目(7212006) 北京市属医学科研院所公益发展改革试点项目(2021-7)。
关键词 脂蛋白(a) 变化趋势 影响因素 Lipoprotein(a) Change trend Influencing factors
  • 相关文献

参考文献4

二级参考文献8

  • 1Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipeprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ, 1990, 301 : 1248-1251.
  • 2Budde T, Fechtrup C, Bosenberg E, et al. Plasma Lp (a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary artefiography for clinically suspected coronary atherosclerosis. Arteriescler Thromb,1994, 14: 1730-1736.
  • 3Sirikci O, Aytekin V, Demiroglu IC et al. Association of lipoprotein(a) concentration and apo (a) isoform size with restenosis after percutaneous transluminal coronary angloplasty. Int J Clin Lab Res,2000, 30:93-99.
  • 4Miyata M, Biro S, Arima S, et al. High serum concentration of lipoprotein (a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with singlevessel disease. Am Heart J, 1996, 132 (2 Pt 1) :269-273.
  • 5David J, Richard A, Rober S, et al. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.Circulation, 1993, 88: 935-940.
  • 6Igarashi Y, Yamaura M, Ito M, et al. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J, 1998 , 136: 965-971.
  • 7Igarashi Y, Kasal H, Yamashita F, et al. Lipoprotein ( a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J, 2000, 64:93-98.
  • 8Wolf PA. Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med, 1987, 147: 1561-1564.

共引文献3084

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部